Cited 5 times in
Comparison of 3-Year Clinical Outcomes Between Resolute™ Zotarolimus- and Sirolimus-Eluting Stents for Long Coronary Artery Stenosis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 신동호 | - |
dc.contributor.author | 임의 | - |
dc.contributor.author | 장양수 | - |
dc.contributor.author | 최동훈 | - |
dc.contributor.author | 홍명기 | - |
dc.contributor.author | 고영국 | - |
dc.contributor.author | 김병극 | - |
dc.contributor.author | 김중선 | - |
dc.date.accessioned | 2014-12-18T08:59:12Z | - |
dc.date.available | 2014-12-18T08:59:12Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 0896-4327 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/87322 | - |
dc.description.abstract | OBJECTIVES: Long-term clinical outcomes were evaluated in long coronary artery stenosis treated with different types of drug-eluting stents. BACKGROUND: Long-term follow-up data to compare clinical outcomes between Resolute™ zotarolimus-eluting stent (R-ZES) versus sirolimus-eluting stent (SES) implantation for long coronary artery stenosis is insufficient. METHODS: A total of 254 patients (307 lesions) treated with R-ZES and 265 patients (303 lesions) treated with SES for long coronary lesions (total stent length ≥ 30 mm) were enrolled, and long-term (3 years) clinical outcomes were compared between the 2 groups. Efficacy (target lesion revascularization [TLR]) and safety (the composite occurrence of cardiovascular death, target lesion-related myocardial infarction, or target lesion-related definite stent thrombosis) were assessed. RESULTS: The 2 groups had similar baseline characteristics except for the duration of dual antiplatelet therapy (23.4 ± 11.2 months in R-ZES-treated patients vs. 27.4 ± 13.9 months in SES-treated patients, P<0.001). Total stent length was similar in R-ZES-treated patients (45.0 ± 19.0 mm) and SES-treated patients (45.4 ± 18.6 mm) (P=0.464). The cumulative TLR rate was 4.6% in R-ZES-treated patients versus 4.6% in SES-treated patients (P=0.911). For safety parameters, R-ZES-treated patients showed a significantly lower rate of the composite occurrence of cardiovascular death, target lesion-related myocardial infarction, or target lesion-related definite stent thrombosis than SES-treated patients (0.4% vs. 2.4%, P=0.042). Particularly, the occurrence of target lesion-related definite stent thrombosis was significantly lower in R-ZES-treated patients than in SES-treated patients (0.0% vs. 2.0%, P=0.028). CONCLUSIONS: R-ZES stents showed superior long-term safety than SES for treating long coronary lesions, while maintaining a similar clinical efficacy. | - |
dc.description.statementOfResponsibility | open | - |
dc.relation.isPartOf | JOURNAL OF INTERVENTIONAL CARDIOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Coronary Angiography | - |
dc.subject.MESH | Coronary Stenosis/diagnostic imaging | - |
dc.subject.MESH | Coronary Stenosis/therapy* | - |
dc.subject.MESH | Drug-Eluting Stents* | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Immunosuppressive Agents/administration & dosage* | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Prosthesis Design | - |
dc.subject.MESH | Prosthesis Implantation | - |
dc.subject.MESH | Sirolimus/administration & dosage* | - |
dc.subject.MESH | Sirolimus/analogs & derivatives* | - |
dc.subject.MESH | Treatment Outcome | - |
dc.title | Comparison of 3-Year Clinical Outcomes Between Resolute™ Zotarolimus- and Sirolimus-Eluting Stents for Long Coronary Artery Stenosis | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | EUI IM | - |
dc.contributor.googleauthor | BYEONG-KEUK KIM | - |
dc.contributor.googleauthor | YOUNG-GUK KO | - |
dc.contributor.googleauthor | AE-YOUNG HER | - |
dc.contributor.googleauthor | HYUN HEE CHOI | - |
dc.contributor.googleauthor | DONG-HO SHIN | - |
dc.contributor.googleauthor | JUNG-SUN KIM | - |
dc.contributor.googleauthor | DONGHOON CHOI | - |
dc.contributor.googleauthor | YANGSOO JANG | - |
dc.contributor.googleauthor | MYEONG-KI HONG | - |
dc.identifier.doi | 10.1111/joic.12047 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A02097 | - |
dc.contributor.localId | A03394 | - |
dc.contributor.localId | A03448 | - |
dc.contributor.localId | A04053 | - |
dc.contributor.localId | A04391 | - |
dc.contributor.localId | A00127 | - |
dc.contributor.localId | A00493 | - |
dc.contributor.localId | A00961 | - |
dc.relation.journalcode | J01465 | - |
dc.identifier.eissn | 1540-8183 | - |
dc.identifier.pmid | 23844852 | - |
dc.identifier.url | http://onlinelibrary.wiley.com/doi/10.1111/joic.12047/abstract | - |
dc.subject.keyword | Aged | - |
dc.subject.keyword | Coronary Angiography | - |
dc.subject.keyword | Coronary Stenosis/diagnostic imaging | - |
dc.subject.keyword | Coronary Stenosis/therapy* | - |
dc.subject.keyword | Drug-Eluting Stents* | - |
dc.subject.keyword | Female | - |
dc.subject.keyword | Humans | - |
dc.subject.keyword | Immunosuppressive Agents/administration & dosage* | - |
dc.subject.keyword | Male | - |
dc.subject.keyword | Middle Aged | - |
dc.subject.keyword | Prosthesis Design | - |
dc.subject.keyword | Prosthesis Implantation | - |
dc.subject.keyword | Sirolimus/administration & dosage* | - |
dc.subject.keyword | Sirolimus/analogs & derivatives* | - |
dc.subject.keyword | Treatment Outcome | - |
dc.contributor.alternativeName | Shin, Dong Ho | - |
dc.contributor.alternativeName | Im, Eui | - |
dc.contributor.alternativeName | Jang, Yang Soo | - |
dc.contributor.alternativeName | Choi, Dong Hoon | - |
dc.contributor.alternativeName | Hong, Myeong Ki | - |
dc.contributor.alternativeName | Ko, Young Guk | - |
dc.contributor.alternativeName | Kim, Byeong Keuk | - |
dc.contributor.alternativeName | Kim, Jung Sun | - |
dc.contributor.affiliatedAuthor | Shin, Dong Ho | - |
dc.contributor.affiliatedAuthor | Im, Eui | - |
dc.contributor.affiliatedAuthor | Jang, Yang Soo | - |
dc.contributor.affiliatedAuthor | Choi, Dong Hoon | - |
dc.contributor.affiliatedAuthor | Hong, Myeong Ki | - |
dc.contributor.affiliatedAuthor | Ko, Young Guk | - |
dc.contributor.affiliatedAuthor | Kim, Byeong Keuk | - |
dc.contributor.affiliatedAuthor | Kim, Jung Sun | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 26 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 378 | - |
dc.citation.endPage | 383 | - |
dc.identifier.bibliographicCitation | JOURNAL OF INTERVENTIONAL CARDIOLOGY, Vol.26(4) : 378-383, 2013 | - |
dc.identifier.rimsid | 32981 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.